These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7625161)

  • 1. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy.
    Larsson HB
    Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
    Paty DW; Li DK; Koopmans R
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):978. PubMed ID: 1431970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
    Rüttinger H; Rüttinger P; Hermes M
    Nervenarzt; 1991 Feb; 62(2):127-9. PubMed ID: 2034308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
    Gowin W; Weihe W; Appel C; Mariss G
    Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis and magnetic resonance imaging: advancement in linking the pictures with the progression.
    Racke MK; Hawker K; Frohman EM
    Arch Neurol; 2001 Jan; 58(1):35-6. PubMed ID: 11176933
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.
    Mattingly G; Baker K; Zorumski CF; Figiel GS
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):145-51. PubMed ID: 1627975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
    Larsson HB; Stubgaard M; Frederiksen JL; Jensen M; Henriksen O; Paulson OB
    Magn Reson Med; 1990 Oct; 16(1):117-31. PubMed ID: 2255233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques.
    Narayana PA; Wolinsky JS; Jackson EF; McCarthy M
    J Magn Reson Imaging; 1992; 2(3):263-70. PubMed ID: 1627860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI.
    Tofts PS; Kermode AG
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):1019-20. PubMed ID: 2507745
    [No Abstract]   [Full Text] [Related]  

  • 14. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.
    Kermode AG; Thompson AJ; Tofts P; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; Rudge P; McDonald WI
    Brain; 1990 Oct; 113 ( Pt 5)():1477-89. PubMed ID: 2245307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig.
    Karlik SJ; Grant EA; Lee D; Noseworthy JH
    Magn Reson Med; 1993 Sep; 30(3):326-31. PubMed ID: 8412603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
    Lai M; Hodgson T; Gawne-Cain M; Webb S; MacManus D; McDonald WI; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):339-41. PubMed ID: 8609517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-DTPA-enhanced lesions in the brain of patients with acute optic neuritis.
    Christiansen P; Frederiksen JL; Henriksen O; Larsson HB
    Acta Neurol Scand; 1992 Feb; 85(2):141-6. PubMed ID: 1574989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of brain magnetic resonance imaging in multiple sclerosis.
    Goodkin DE; Rudick RA; Ross JS
    Arch Neurol; 1994 May; 51(5):505-16. PubMed ID: 8179501
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.
    van Walderveen MA; Tas MW; Barkhof F; Polman CH; Frequin ST; Hommes OR; Valk J
    Neurology; 1994 Feb; 44(2):327-9. PubMed ID: 8309584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.